XML 32 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Impact of adoption of new accounting standards
 [1]
Adjusted balance at beginning of period
Common shares outstanding
Common shares outstanding
Adjusted balance at beginning of period
Common Stock
Common Stock
Adjusted balance at beginning of period
Surplus
Surplus
Adjusted balance at beginning of period
Accumulated Deficit
Accumulated Deficit
Impact of adoption of new accounting standards
Accumulated Deficit
Adjusted balance at beginning of period
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Adjusted balance at beginning of period
Non-Controlling Interests
Non-Controlling Interests
Adjusted balance at beginning of period
Balance at Dec. 31, 2019 $ 528,520 $ (3,156) $ 525,364     $ 447,602 $ 447,602 $ 91,611 $ 91,611 $ (19,102) $ (3,156) $ (22,258) $ 8,409 $ 8,409 $ 0 $ 0
Balance (in shares) at Dec. 31, 2019       28,289,257 28,289,257                      
Increase (Decrease) in Shareholders' Equity                                
Net income 37,273                 37,273            
Other comprehensive income (loss) 11,719                       11,719      
Cash dividends (25,935)                 (25,935)            
Common stock purchased by directors' deferred compensation plan (218)         (218)                    
Common stock repurchased and other related costs (in shares)       (206,802)                        
Common stock repurchased and other related costs (4,749)         (4,749)                    
Share-based compensation (in shares)       100,885                        
Share-based compensation expense 3,231             3,231                
Non-controlling interest (48)                           (48)  
Balance at Dec. 31, 2020 546,733         442,635   94,842   (10,920)     20,128   48  
Balance (in shares) at Dec. 31, 2020       28,183,340                        
Increase (Decrease) in Shareholders' Equity                                
Net income 79,894                 79,894            
Other comprehensive income (loss) (28,088)                       (28,088)      
Cash dividends (26,959)                 (26,959)            
Common stock purchased by directors' deferred compensation plan 889         889                    
Common stock repurchased and other related costs (in shares)       (696,894)                        
Common stock repurchased and other related costs (18,669)         (18,669)                    
Share-based compensation (in shares)       227,625                        
Share-based compensation expense 4,467         1,236   3,231                
Balance at Dec. 31, 2021 $ 558,267         426,091   98,073   42,015     (7,960)   48  
Balance (in shares) at Dec. 31, 2021 27,714,071     27,714,071                        
Increase (Decrease) in Shareholders' Equity                                
Net income $ 73,928                 73,928            
Other comprehensive income (loss) (136,024)                       (136,024)      
Cash dividends (28,505)                 (28,505)            
Common stock purchased by directors' deferred compensation plan 2,041         2,041                    
Common stock repurchased and other related costs (in shares)       (868,613)                        
Common stock repurchased and other related costs (20,740)         (20,740)                    
Share-based compensation (in shares)       179,612                        
Share-based compensation expense 3,952         679   3,273                
Non-controlling interest 48                           48  
Balance at Dec. 31, 2022 $ 452,871         $ 408,071   $ 101,346   $ 87,438     $ (143,984)   $ 0  
Balance (in shares) at Dec. 31, 2022 27,025,070     27,025,070                        
[1] Represents the impact of the adoption of Accounting Standards Update ("ASU") ASU 2016-01.